US Medicare Agency Alters Payments For Use Of Telehealth Tech, Lab Specimen Collection For COVID-19

An interim final rule posted by the CMS this week widens further a series of telehealth exemptions and lab specimen collection payment provisions it has previously issued to help providers during the COVID-19 pandemic.

MT2004_COVID19 Blood-Dollars_1681700695 _1200.jpg

The Centers for Medicare and Medicaid Services (CMS) announced on 6 April a long series of exemptions from usual payment regulations it is permitting for extended telehealth technology use to protect health care providers as the coronavirus crisis continues. A second part of the interim final rule provides special lab specimen collection fees to be paid to independent laboratories when they retrieve COVID-19 tests from homebound and non-hospital health care facility inpatients.

The changes – which are retroactive to include episodes of care and dates of service beginning on 1 March 2020 – are aimed at giving providers and the Medicare and...

More from Legislation

More from Policy & Regulation